Skip to main content

Table 2 Baseline clinical and treatment related characteristics of children on ART at University of Gondar Comprehensive Specialized Hospital, 2017 (n = 402)

From: Late antiretroviral therapy initiation and associated factors among children on antiretroviral therapy at University of Gondar Comprehensive Specialized Hospital, Gondar, Northwest Ethiopia: a cross-sectional study

Variables

Frequency (n)

Percentage (%)

Duration between HIV test confirmed and enrollment

 < 6 months

291

72.4

 6–12 months

46

11.4

 > 12 months

65

16.2

Any medication before ART initiation

 No

299

74.4

 Yes

103

25.6

Past OI at enrollment

 No

214

53.2

 Yes

188

46.8

Cotrimoxazole prophylaxis

 No

42

10.4

 Yes

360

89.6

INH prophylaxis

 No

338

84.1

 Yes

64

15.9

TB treatment history

 No

336

83.6

 Yes

66

16.4

Chronic disease

 No

324

80.6

 Yes

78

19.4

Immunization status

 Appropriate for age

323

80.3

 Not appropriate for age

67

16.7

 Not Immunized

12

3

WHO stage at HIV test

 I

136

33.8

 II

133

33.1

 III

98

24.4

 IV

35

8.7

Functional status (≥ 5 years)

 Working

120

47.8

 Ambulatory/bedridden

131

52.2

Developmental milestone (< 5 years)

 Appropriate ranges for age

116

76.8

 Developmental delay/regression

35

23.2

CD4 count (> 5 years)

 < 250 cells/mm3

50

20.2

 ≥ 250 cells/mm3

198

79.8

CD4 percentage (≤ 5 years)

 < 15%

37

24.0

 15–25%

39

25.3

 > 25%

78

50.7

WHO stage at ART initiation

 I

94

23.4

 II

136

33.8

 III

130

32.3

 IV

42

10.5

Year of ART initiation

 2007–2008

69

17.2

 2009–2011

137

34.1

 2012–2014

115

28.6

 2015–2016

81

20.1